Keywords: |
cancer survival; treatment outcome; disease-free survival; oncoprotein; genetics; mortality; cancer risk; note; disease free survival; outcome assessment; gene expression profiling; diagnosis, differential; differential diagnosis; risk factors; editorial; pathology; chromosomes, human, pair 8; risk factor; histology; morphology; time; time factors; risk assessment; gene expression regulation; gene expression regulation, neoplastic; gene fusion; oncogene proteins, fusion; prediction and forecasting; predictive value of tests; medical literature; rhabdomyosarcoma; chromosome 8; genetic screening; embryonal rhabdomyosarcoma; rhabdomyosarcoma, embryonal; genetic testing; paired box transcription factor; paired box transcription factors; rhabdomyosarcoma, alveolar; pax3 foxo1a fusion protein, human; pax3 protein, human; pax3-foxo1a fusion protein, human; pax7 protein, human; transcription factor pax7; pax7 transcription factor
|